Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uma Borate

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Blood Neoplasia|January 5, 2026
Safety of gemtuzumab ozogamicin with cytarabine, daunorubicin, and midostaurin induction in FLT3-mutated AMLJayanshu Jain, Kelly Pugh, Shivani Handa, et al.
Blood|September 5, 2021
Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult patients with AMLFei Yang, Nicola Long, Tauangtham Anekpuritanang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 13, 2013
Myelodysplastic syndromes: clinical practice guidelines in oncologyPeter L Greenberg, Eyal Attar, John M Bennett, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|November 9, 2025
A proposed path to explaining the unexplained anemia of agingNahed El Kassar, Amy E DeZern, Janis Abkowitz, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 11, 2012
NCCN Clinical Practice Guidelines Acute myeloid leukemiaMargaret R O'Donnell, Camille N Abboud, Jessica Altman, et al.
Cancer Discovery|October 12, 2022
Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired ResistanceJunhua Lyu, Yuxuan Liu, Lihu Gong, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 14, 2013
Acute myeloid leukemia, version 2.2013Margaret R O'Donnell, Martin S Tallman, Camille N Abboud, et al.
Hemasphere|May 22, 2024
Toward a more patient-centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS)Fabio Efficace, Rena Buckstein, Gregory A Abel, et al.
Cancer Research Communications|June 25, 2025
A Phase 1b/2 Study of TP-0903 and Decitabine Targeting Mutant TP53 and/or Complex Karyotype in Patients with Untreated Acute Myeloid Leukemia ≥Age 60 YearsEric D Eisenmann, Ronan Swords, Ying Huang, et al.
Blood Advances|July 17, 2023
Samples from patients with AML show high concordance in detection of mutations by NGS at local institutions vs central laboratoriesUma Borate, Fei Yang, Richard Press, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Blood Neoplasia|January 5, 2026
Safety of gemtuzumab ozogamicin with cytarabine, daunorubicin, and midostaurin induction in FLT3-mutated AMLJayanshu Jain, Kelly Pugh, Shivani Handa, et al.
Blood|September 5, 2021
Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult patients with AMLFei Yang, Nicola Long, Tauangtham Anekpuritanang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 13, 2013
Myelodysplastic syndromes: clinical practice guidelines in oncologyPeter L Greenberg, Eyal Attar, John M Bennett, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|November 9, 2025
A proposed path to explaining the unexplained anemia of agingNahed El Kassar, Amy E DeZern, Janis Abkowitz, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 11, 2012
NCCN Clinical Practice Guidelines Acute myeloid leukemiaMargaret R O'Donnell, Camille N Abboud, Jessica Altman, et al.
Cancer Discovery|October 12, 2022
Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired ResistanceJunhua Lyu, Yuxuan Liu, Lihu Gong, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 14, 2013
Acute myeloid leukemia, version 2.2013Margaret R O'Donnell, Martin S Tallman, Camille N Abboud, et al.
Hemasphere|May 22, 2024
Toward a more patient-centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS)Fabio Efficace, Rena Buckstein, Gregory A Abel, et al.
Cancer Research Communications|June 25, 2025
A Phase 1b/2 Study of TP-0903 and Decitabine Targeting Mutant TP53 and/or Complex Karyotype in Patients with Untreated Acute Myeloid Leukemia ≥Age 60 YearsEric D Eisenmann, Ronan Swords, Ying Huang, et al.
Blood Advances|July 17, 2023
Samples from patients with AML show high concordance in detection of mutations by NGS at local institutions vs central laboratoriesUma Borate, Fei Yang, Richard Press, et al.
Pageof 6